Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The Effects of Chitosan-PEG Nanoparticles Based on Channa striata Protein Hydrolyzate on Decreasing Diabetes Mellitus in Diabetic Rats

View through CrossRef
BACKGROUND: Channa striata has several good nutrients, including 70% protein, 20% albumin, complete amino acids, zinc, selenium, and iron. However, no study has investigated the chitosan-PEG nanoparticles based on Channa striata protein hydrolyzate. This study’s purpose was to determine the role of 10% Channa striata protein hydrolyzate, chitosan-PEG 4000 nanoparticles, and chitosan- PEG 6000 nanoparticles in reducing diabetes mellitus in diabetic rats.METHOD: A randomized pretest-posttest control group design was used, with male Sprague–Dawley rats being divided into five groups: STZ, acarbose, hydrolyzate, chitosan-PEG 4000 nanoparticles, and chitosan-PEG 6000 nanoparticles. Diabetes was induced by a single injection of streptozotocin at 1 ml in each formulation. Blood glucose levels were analyzed using a glucometer 7, 14, and 21 days after treatment. The CHOD-PAP method was used to analyze the lipid profile. Pancreas and liver histology analyses were carried out using a microscope.RESULTS: The formulation of 10% Channa striata protein hydrolyzate and PEG 6000 was the most effective in lowering blood glucose concentrations, and the response was close to the acarbose result. The glucose concentration decreased after daily oral administration of chitosan-PEG nanoparticles for 21 days. The plasma cholesterol, triglycerides, LDL, and HDL concentrations were lower in treated than in untreated diabetic rats.CONCLUSION: This study concluded that the formulation of 10% Channa striata protein hydrolyzate and chitosan-PEG 6000 nanoparticles was more effective than acarbose.
Title: The Effects of Chitosan-PEG Nanoparticles Based on Channa striata Protein Hydrolyzate on Decreasing Diabetes Mellitus in Diabetic Rats
Description:
BACKGROUND: Channa striata has several good nutrients, including 70% protein, 20% albumin, complete amino acids, zinc, selenium, and iron.
However, no study has investigated the chitosan-PEG nanoparticles based on Channa striata protein hydrolyzate.
This study’s purpose was to determine the role of 10% Channa striata protein hydrolyzate, chitosan-PEG 4000 nanoparticles, and chitosan- PEG 6000 nanoparticles in reducing diabetes mellitus in diabetic rats.
METHOD: A randomized pretest-posttest control group design was used, with male Sprague–Dawley rats being divided into five groups: STZ, acarbose, hydrolyzate, chitosan-PEG 4000 nanoparticles, and chitosan-PEG 6000 nanoparticles.
Diabetes was induced by a single injection of streptozotocin at 1 ml in each formulation.
Blood glucose levels were analyzed using a glucometer 7, 14, and 21 days after treatment.
The CHOD-PAP method was used to analyze the lipid profile.
Pancreas and liver histology analyses were carried out using a microscope.
RESULTS: The formulation of 10% Channa striata protein hydrolyzate and PEG 6000 was the most effective in lowering blood glucose concentrations, and the response was close to the acarbose result.
The glucose concentration decreased after daily oral administration of chitosan-PEG nanoparticles for 21 days.
The plasma cholesterol, triglycerides, LDL, and HDL concentrations were lower in treated than in untreated diabetic rats.
CONCLUSION: This study concluded that the formulation of 10% Channa striata protein hydrolyzate and chitosan-PEG 6000 nanoparticles was more effective than acarbose.

Related Results

Synthesis and Investigation into Apatite-forming Ability of Hydroxyapatite/Chitosan-based Scaffold
Synthesis and Investigation into Apatite-forming Ability of Hydroxyapatite/Chitosan-based Scaffold
In this study, porous scaffolds were fabricated using inorganic material-hydroxyapatite and chitosan for bone-tissue engineering. The combination of hydroxyapatite and chitosan may...
BIODEGRADATION OF CHITOSAN MEMBRANE SCALES OF HARUAN FISH (Channa striata)-HYDROXYAPATITE IN ARTIFICIAL SALIVA SOLUTION
BIODEGRADATION OF CHITOSAN MEMBRANE SCALES OF HARUAN FISH (Channa striata)-HYDROXYAPATITE IN ARTIFICIAL SALIVA SOLUTION
Background: Membrane materials for surgical procedures using Guided Tissue Regeneration (GTR) are Polytetrafluoroethylene (PTFE) and collagen, but have the disadvantage of requirin...
7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
7 th International Symposium on Enabling Technologies for Life Sciences (ETP)
The seventh in the series of ETP Symposia (see Rapid Communications in Mass Spectrometry 2012, 26 , ...
SGOT and SGPT level of Wistar rat after the administration of Channa micropeltes extract
SGOT and SGPT level of Wistar rat after the administration of Channa micropeltes extract
Channa micropeltes is a local peatland water species which has been utilized as an alternative of Channa striata among South Kalimantan population to anticipate the scarcity of Har...
PENURUNAN KADAR GULA DARAH DAN RESIKO ULKUS PADA PENDERITA DIABETES MELLITUS DENGAN SENAM KAKI DIABETES
PENURUNAN KADAR GULA DARAH DAN RESIKO ULKUS PADA PENDERITA DIABETES MELLITUS DENGAN SENAM KAKI DIABETES
ABSTRAKDiabetes mellitus adalah suatu penyakit dengan peningkatan glukosa darah di atas normal. Indonesia merupakan negara menempati urutan ke 7 dengan penderita diabetes mellitus ...
PENGARUH PERENDAMAN GIGI PADA KITOSAN SISIK IKAN HARUAN (Channa striata) TERHADAP PELEPASAN FOSFAT
PENGARUH PERENDAMAN GIGI PADA KITOSAN SISIK IKAN HARUAN (Channa striata) TERHADAP PELEPASAN FOSFAT
Background: Chitosan solution from Haruan fish scales (Channa striata) can be used to maintain tooth enamel structure by reducing the rate of solubility of hydroxyapatite or tooth ...
Efektivitas Ekstrak Ikan Gabus sebagai Antihiperglikemik
Efektivitas Ekstrak Ikan Gabus sebagai Antihiperglikemik
Diabetes melitus merupakan penyakit metabolik yang ditandai dengan meningkatkan kadar glukosa darah atau penderita dalam kondisi hiperglikemik. Jumlah penderita diabetes melitus di...

Back to Top